2021
Failure Mode and Effect Analysis: Engineering Safer Neurocritical Care Transitions
Chilakamarri P, Finn EB, Sather J, Sheth KN, Matouk C, Parwani V, Ulrich A, Davis M, Pham L, Chaudhry SI, Venkatesh AK. Failure Mode and Effect Analysis: Engineering Safer Neurocritical Care Transitions. Neurocritical Care 2021, 35: 232-240. PMID: 33403581, PMCID: PMC8255326, DOI: 10.1007/s12028-020-01160-6.Peer-Reviewed Original ResearchConceptsPatient safetyInter-hospital transferEmergency department throughputIntracerebral hemorrhageAcute careSubarachnoid hemorrhageNeurocritical careCare transitionsMulti-disciplinary teamPatient transferHemorrhageSignificant reductionInterventionCareHazard analysisOutcomesRiskSafetyMultiple providersSpecific use-case examplesEvidence of successPatientsStrokeMethodsWe
1999
Lorazepam for the Prevention of Recurrent Seizures Related to Alcohol
D'Onofrio G, Rathlev N, Ulrich A, Fish S, Freedland E. Lorazepam for the Prevention of Recurrent Seizures Related to Alcohol. New England Journal Of Medicine 1999, 340: 915-919. PMID: 10094637, DOI: 10.1056/nejm199903253401203.Peer-Reviewed Original ResearchConceptsPlacebo groupRecurrent seizuresSecond seizureLorazepam groupEmergency departmentNormal salineAlcohol abusePrimary end pointDouble-blind studyChronic alcohol abuseYears of ageIntravenous lorazepamHospital dischargeConsecutive patientsGeneralized seizuresEntry criteriaCommon causePatientsSeizuresEnd pointLorazepamObservation periodSignificant reductionHospitalSaline